GBS Inc. to Present First Quarter 2022 Financial Results and Recent Corporate Update on November 11

Rhea-AI Summary

GBS Inc., a life sciences company focusing on non-invasive diagnostic testing, will announce its financial results for the first quarter ending September 30, 2021, after the market closes on November 11, 2021. Following this, management will host a conference call at 4:30 p.m. ET to discuss the results. Investors and stakeholders can access the live webcast on the company's website. GBS is known for its innovative Biosensor Platform aimed at improving diabetes care.

Positive

• None.

Company to Host Conference Call & Webcast at 4:30 p.m. ET

NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the first quarter ended September 30, 2021, shortly after the NASDAQ market close on Thursday, November 11. Management will then host a conference call and webcast at 4:30 p.m. ET.

Title:	GBS, Inc. First Quarter 2022 Financial Results Conference Call & Webcast
Date:	Thursday, November 11, 2021
Time:	4:30 p.m. ET
Conference Call Details:	Toll-Free: 877-407-3982 International: 201-493-6780 Conference ID: 13724335
The conference call will be webcast live from the Company’s website and will be available via the following links:
Webcast:	Webcast Registration Link https://78449.themediaframe.com/dataconf/productusers/vvdb/mediaframe/47098/indexl.html https://investors.gbs.inc/news-and-events/investor-calendar
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company’s website.

About GBS Inc.

GBS Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help people living with diabetes. For more information, please visit GBS.inc.        

Investor Contact:
Tim McCarthy – Managing Director
LifeSci Advisors, LLC
Tim@LifeSciAdvisors.com

Company Contact:
Spiro Sakiris – Chief Financial Officer
GBS, Inc.
Investor.Relations@gbs.inc

FAQ

When will GBS Inc. release its first quarter financial results?

GBS Inc. will release its first quarter financial results on November 11, 2021, after market close.

What time is the GBS Inc. conference call?

The GBS Inc. conference call is scheduled for 4:30 p.m. ET on November 11, 2021.

How can I access the GBS Inc. conference call webcast?

The GBS Inc. conference call webcast can be accessed through the company's website on November 11, 2021.

What is the focus of GBS Inc.'s Biosensor Platform?

The GBS Inc. Biosensor Platform is focused on developing non-invasive diagnostic tests for diabetes care.